K002334

Substantially Equivalent

MACROPORENS CRANILOC

Applicant: Macropore Biosurgery, Inc.
Product code: GXR
Advisory panel: Neurology
Date received: 2000-08-01
Decision date: 2001-05-02
Decision: Substantially Equivalent
Clearance type: Traditional
Location: San Diego, CA, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.